180 related articles for article (PubMed ID: 26791563)
1. Oxadiazole-2-oxides may have other functional targets, in addition to SjTGR, through which they cause mortality in Schistosoma japonicum.
Song LJ; Luo H; Fan WH; Wang GP; Yin XR; Shen S; Wang J; Jin Y; Zhang W; Gao H; Liu Q; Wang WL; Feng B; Yu CX
Parasit Vectors; 2016 Jan; 9():26. PubMed ID: 26791563
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of oxadiazole-2-oxide derivatives as potential drug candidates for schistosomiasis targeting SjTGR.
Li G; Guo Q; Feng C; Chen H; Zhao W; Li S; Hong Y; Sun D
Parasit Vectors; 2021 Apr; 14(1):225. PubMed ID: 33902686
[TBL] [Abstract][Full Text] [Related]
3. Molecular docking to explore the possible binding mode of potential inhibitors of thioredoxin glutathione reductase.
Huang J; Hua W; Li J; Hua Z
Mol Med Rep; 2015 Oct; 12(4):5787-95. PubMed ID: 26239395
[TBL] [Abstract][Full Text] [Related]
4. Thioredoxin glutathione reductase as a novel drug target: evidence from Schistosoma japonicum.
Song L; Li J; Xie S; Qian C; Wang J; Zhang W; Yin X; Hua Z; Yu C
PLoS One; 2012; 7(2):e31456. PubMed ID: 22384025
[TBL] [Abstract][Full Text] [Related]
5. Small change, big difference: A promising praziquantel derivative designated P96 with broad-spectrum antischistosomal activity for chemotherapy of schistosomiasis japonica.
Xu J; Dong LL; Sun H; Huang P; Zhang RZ; Wang XY; Sun DQ; Xia CM
PLoS Negl Trop Dis; 2023 Jul; 17(7):e0011215. PubMed ID: 37410790
[TBL] [Abstract][Full Text] [Related]
6. [Toxicity of several drugs against Schistosoma japonicum adult worms in vitro].
Song LJ; Yu CX; Zeng HH; Qian CY; Yin XR; Wang J; Hua WQ; Xu YL; Zhang W
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Feb; 23(1):54-60. PubMed ID: 22164376
[TBL] [Abstract][Full Text] [Related]
7. [Studies on resistance of Schistosoma to praziquantel XIV experimental comparison of susceptibility to praziquantel between PZQ-resistant isolates and PZQ-susceptible isolates of Schistosoma japonicum in stages of adult worms, miracidia and cercariae].
Li HJ; Liang YS; Dai JR; Wang W; Qu GL; Li YZ; Xing YT; Tao YH; Qian K; Jia Y; Yang ZK; Wei JY
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Dec; 23(6):611-9. PubMed ID: 22379813
[TBL] [Abstract][Full Text] [Related]
8. [Studies on resistance of Schistosoma to praziquantel XIII resistance of Schistosoma japonicum to praziquantel is experimentally induced in laboratory].
Liang YS; Li HJ; Dai JR; Wang W; Qu GL; Tao YH; Xing YT; Li YZ; Qian K; Wei JY
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Dec; 23(6):605-10. PubMed ID: 22379812
[TBL] [Abstract][Full Text] [Related]
9. Praziquantel derivatives exhibit activity against both juvenile and adult Schistosoma japonicum.
Duan WW; Qiu SJ; Zhao Y; Sun H; Qiao C; Xia CM
Bioorg Med Chem Lett; 2012 Feb; 22(4):1587-90. PubMed ID: 22264473
[TBL] [Abstract][Full Text] [Related]
10. Identification of Peptide Antagonists to Thioredoxin Glutathione Reductase of
Song LJ; Li JH; Yin XR; Zhang W; Jin Y; Gao H; Wang J; Yu CX; Hua ZC
Biomed Res Int; 2018; 2018():9483928. PubMed ID: 29967790
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of combination chemotherapy with praziquantel and DW-3-15 for Schistosoma japonicum in vitro and in vivo.
Yang ZY; Liu ZH; Zhang YN; Li C; Liu L; Pu WJ; Xie SQ; Xu J; Xia CM
Parasit Vectors; 2021 Oct; 14(1):550. PubMed ID: 34702326
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum.
Wang X; Yu D; Li C; Zhan T; Zhang T; Ma H; Xu J; Xia C
Parasit Vectors; 2019 May; 12(1):199. PubMed ID: 31053083
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the antischistosomal effect of levo- and dextro-praziquantel on Schistosoma japonicum and S. mansoni in mice.
Tanaka M; Ohmae H; Utsunomiya H; Nara T; Irie Y; Yasuraoka K
Am J Trop Med Hyg; 1989 Aug; 41(2):198-203. PubMed ID: 2505624
[TBL] [Abstract][Full Text] [Related]
14. Schistosoma japonicum-infected hamsters (Mesocricetus auratus) used as a model in experimental chemotherapy with praziquantel, artemether, and OZ compounds.
Xiao SH; Mei JY; Jiao PY
Parasitol Res; 2011 Feb; 108(2):431-7. PubMed ID: 20922422
[TBL] [Abstract][Full Text] [Related]
15. Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis.
Rai G; Sayed AA; Lea WA; Luecke HF; Chakrapani H; Prast-Nielsen S; Jadhav A; Leister W; Shen M; Inglese J; Austin CP; Keefer L; Arnér ES; Simeonov A; Maloney DJ; Williams DL; Thomas CJ
J Med Chem; 2009 Oct; 52(20):6474-83. PubMed ID: 19761212
[TBL] [Abstract][Full Text] [Related]
16. Identification of oxadiazoles as new drug leads for the control of schistosomiasis.
Sayed AA; Simeonov A; Thomas CJ; Inglese J; Austin CP; Williams DL
Nat Med; 2008 Apr; 14(4):407-12. PubMed ID: 18345010
[TBL] [Abstract][Full Text] [Related]
17. [Expression and characterization of thioredoxin glutathione reductase of Schistosoma japonicum].
Song LJ; Yu CX; Xie SY; Yin XR; Qian CY; Wang J; Zhang W; Ke XD
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Aug; 23(4):412-8. PubMed ID: 22164854
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of artemether and artesunate in mice infected with praziquantel non-susceptible isolate of Schistosoma japonicum.
Wang W; Li TY; Ji Y; Qu GL; Qian YL; Li HJ; Dai JR; Liang YS
Parasitol Res; 2014 Mar; 113(3):925-31. PubMed ID: 24326467
[TBL] [Abstract][Full Text] [Related]
19. Schistosoma japonicum and S. mansoni: ultrastructural damage in the tegument and reproductive organs after treatment with levo- and dextro-praziquantel.
Irie Y; Utsunomiya H; Tanaka M; Ohmae H; Nara T; Yasuraoka K
Am J Trop Med Hyg; 1989 Aug; 41(2):204-11. PubMed ID: 2505625
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of praziquantel and endoperoxide conjugates as antischistosomal agents.
Yang JJ; Boissier J; Chen JL; Yao H; Yang S; Rognon A; Qiao C
Future Med Chem; 2015; 7(6):713-25. PubMed ID: 25996065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
